Rational deployment of antimalarial drugs in Africa: Ahould first-line combination drugs be reserved for paediatric malaria cases?

Parasitology

Volumn 138, Issue 12, 2011, Pages 1459-1468

  Sutherland, Colin J ^a   Babiker, Hamza ^b,c   MacKinnon, Margaret J ^d,e   Ranford Cartwright, Lisa ^f   Sayed, Badria Babiker E L ^g  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b SULTAN QABOOS UNIVERSITY   (Oman)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

^g TROPICAL MEDICINE RESEARCH INSTITUTE   (Sudan)

Author keywords

drug resistance; Malaria; rational therapeutics

Indexed keywords

ANKYRIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CARBAMAZEPINE; CHOLECYSTOKININ; CLOZAPINE; CYCLIN DEPENDENT KINASE 5; GLUTAMATE AMMONIA LIGASE; GLUTAMATE RECEPTOR; HALOPERIDOL; LITHIUM; MESSENGER RNA; MYOSIN; NEUROPILIN 1; NEUROTROPHIN 3; PREPROTACHYKININ; PROENKEPHALIN; RNA; VALPROIC ACID; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ALCOHOL ABUSE; AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ARTICLE; ASTROCYTE; AUTOPSY; BIPOLAR DISORDER; BRAIN TISSUE; CATECHOLAMINERGIC SYSTEM; DRUG ABUSE; EPITHELIUM CELL; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HIPPOCAMPUS; HOSPITALIZATION; HUMAN; MICROGLIA; MOOD CHANGE; NERVE CELL; NEUROTRANSMISSION; OLIGODENDROGLIA; PHARMACOGENOMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; ADULT; AFRICA; CHILD; DRUG COMBINATION; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; INFANT; MALARIA, FALCIPARUM; NEWBORN; PARASITOLOGY; PLASMODIUM FALCIPARUM; PREGNANCY; PRESCHOOL CHILD; TRANSMISSION;

PLASMODIUM FALCIPARUM;

ADOLESCENT; ADULT; AFRICA; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PREGNANCY;

EID: 84855698085     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182011001144     Document Type: Article

References (51)

1. Abdel-Muhsin, A. M., Mackinnon, M. J., Ali, E., Nassir, el-K. A., Suleiman, S., Ahmed, S., Walliker, D. and Babiker, H. A. (2004). Evolution of drug-resistance genes in Plasmodium falciparum in an area of seasonal malaria transmission in Eastern Sudan. Journal of Infectious Diseases 189, 1239-1244.
2. Adam, I., Osman, M. E., Elghzali, G., Ahmed, G. I., Gustafssons, L. L. and Elbashir, M. I. (2004). Efficacies of chloroquine, sulfadoxinepyrimethamine and quinine in the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan. Annals of Tropical Medicine and Parasitology 98, 661-666.
3. Al-Saai, S., Kheir, A., Abdel-Muhsin, A. M., Al-Ghazali, A., Nwakanma, D., Swedberg, G. and Babiker, H. A. (2009). Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan. Infection, Genetics and Evolution 9, 778-783.
4. Babiker, H. A., S. Pringle, A. Abdel-Muhsin, M. Mackinnon, P. Hunt and D. Walliker (2001). High level chloroquine resistance in Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene Pfcrt and the multi-drug resistance gene Pfmdr1. Journal of Infectious Diseases 183, 1535-1538.
5. Babiker, H. A., Satti, G., Ferguson, H., Bayoumi, R. and Walliker, D. (2005). Drug resistant Plasmodium falciparum in an area of seasonal transmission. Acta Tropica 94, 260-268.
6. Bayoumi, R. A., Babiker, H. A., Ibrahim, S. M., Ghalib, H.W.,Saeed, B. O., Khider, S., Elwasila, M. and Karim, E. A. (1989). Chloroquine-resistant Plasmodium falciparum in eastern Sudan. Acta Tropica 46, 157-165.
7. Bayoumi, R. A., Creasey, A. M., Babiker, H. A., Carlton, J. M., Sultan, A. A., Satti, G., Sohal, A. K., Walliker, D., Jensen, J. B. and Arnot, D. E. (1993). Drug response and genetic characterization of Plasmodium falciparum clones recently isolated from a Sudanese village. Transactions of the Royal Society of Tropical Medicine and Hygiene 87, 454-458.
8. Beshir, K., Hallett, R. L., Eziefula, A. C., Bailey, R., Watson, J., Wright, S. G., Chiodini, P. L., Polley, S. D. and Sutherland, C. J. (2010a). Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance. Malaria Journal 9, 312.
9. Beshir, K., Sutherland, C. J., Merinopoulos, I., Durrani, N., Leslie, T., Rowland, M. and Hallett, R. L. (2010b). Amodiaquine resistance in Plasmodium falciparum malaria in Afghanistan is associated with the pfcrt SVMNT allele at codons 72 to 76. Antimicrobial Agents and Chemotherapy 54, 3714-3716.
10. Bojang, K., Akor, F., Bittaye, O., Conway, D., Bottomley, C.,Milligan, P. and Greenwood, B. M. (2010). A randomised trial to compare the safety, tolerability and efficacy of three drug combinations for intermittent preventive treatment in children. PLoS One. 5, e11225.
11. Bouchaud, O., Imbert, P., Touze, J. E., Dodoo, A. N., Danis, M. and Legros, F. (2009). Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base. Malaria Journal 8, 289.
12. Bousema, J. T., Schneider, P., Gouagna, L. C., Drakeley, C. J., Tostmann, A., Houben, R., Githure, J. I., Ord, R., Sutherland, C. J., Omar, S. A. and Sauerwein, R.W. (2006). Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. Journal of Infectious Diseases 193, 1151-1159.
13. Carrara, V. I., Zwang, J., Ashley, E. A., Price, R. N., Stepniewska, K., Barends, M., Brockman, A., Anderson, T., McGready, R., Phaiphun, L., Proux, S., van Vugt, M., Hutagalung, R., Lwin, K. M., Phyo, A. P., Preechapornkul, P., Imwong, M., Pukrittayakamee, S., Singhasivanon, P., White, N. J. and Nosten, F. (2009). Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One 4, e4551.
14. Cisse, B., Cairns, M., Faye, E., NDiaye, O., Faye, B., Cames, C., Cheng, Y., NDiaye, M., Lǒ, A. C., Simondon., K., Trape, J. F., Faye, O., NDiaye, J. L., Gaye, O., Greenwood, B. and Milligan, P. (2009). Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children. PLoS One 4, e7164.
15. Diallo, D., Sutherland, C., Nebié, I., Konaté, A., Ord, R., Pota, H., Roper, C., Ilboudo-Sanogo, E., Greenwood, B. and Cousens, S. (2007). Children in Burkina Faso protected by insecticide treated materials are able to clear drug resistant parasites better than unprotected children. Journal of Infectious Diseases 196, 138-144.
16. Dokomajilar, C., Nsobya, S. L., Greenhouse, B., Rosenthal, P. J. and Dorsey, G. (2006). Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrobial Agents and Chemotheapy, 50, 1893-1895.
17. Dondorp, A. M., Fanello, C. I., Hendriksen, I. C., Gomes, E., Seni, A., Chhaganlal, K. D., Bojang, K., Olaosebikan, R., Anunobi, N., Maitland, K., Kivaya, E., Agbenyega, T., Nguah, S. B., Evans, J., Gesase, S., Kahabuka, C., Mtove, G., Nadjm, B., Deen, J., Mwanga- Amumpaire, J., Nansumba, M., Karema, C., Umulisa, N., Uwimana, A., Mokuolu, O. A., Adedoyin, O. T., Johnson, W. B., Tshefu, A. K., Onyamboko, M. A., Sakulthaew, T., Ngum, W. P., Silamut, K., Stepniewska, K., Woodrow, C. J., Bethell, D., Wills, B., Oneko, M., Peto, T. E., von Seidlein, L., Day, NP. and White, N. J. (2010). AQUAMAT group. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label,randomised trial. Lancet 376, 1647-1657.
18. Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., Ringwald, P., Silamut, K., Imwong, M., Chotivanich, K., Lim, P., Herdman, T., An, S. S., Yeung, S., Singhasivanon, P., Day, N. P., Lindegardh, N., Socheat, D. and White, N. J. (2009). Artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine 361, 455-467.
19. Dunyo,, S., Milligan, P., Edwards, T., Sutherland, C., Targett, G. and Pinder, M. (2006). Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum. PLoS Clinical Trials 1, e20.
20. Duraisingh, M. T., Drakeley, C. J., Muller, O., Bailey, R., Snounou, G., Targett, G. A. T., Greenwood, B. M., and Warhurst, D. C. (1997). Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine. Parasitology 114, 205-211.
21. Duraisingh, M. T., Jones, P., Sambou, I., von Seidlein, L., Pinder, M., and Warhurst, D. C. (2000). The tyrosine-86 allele of pfmdr1 gene of the Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Molecular and Biochemical Parasitology 108, 13-23.
22. El-Sayed, B., El-Zaki, S. E., Babiker, H., Gadalla, N., Ageep, T., Mansour, F., Baraka, O., Milligan, P. and Babiker, A. (2007). A randomized open-label trial of artesunate-sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan. PLoS One 2, e1311.
23. Elamin, S. B.,Awad, A. I., Eltayeb, I. B., Elmardi, K. A., Hassan, A. H., Mohamed, A. O., Malik, E. M. and Mohamad, T. A. (2010). Descriptive study on the efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Sudan. European Journal of Clinical Pharmacology 66, 231-237.
24. Gadalla, N. B., Elzaki, S. E., Mukhtar, E., Warhurst, D. C., El-Sayed, B. and Sutherland, C. J. (2010). Dynamics of Pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum. Malaria Journal 9, 74.
25. Gosling, R. D., Drakeley, C. J., Mwita, A. and Chandramohan, D. (2008). Presumptive treatment of fever cases as malaria: help or hindrance for malaria control? Malaria Journal 7, 132.
26. Hallett, R. L., Dunyo, S., Ord, R., Jawara, M., Pinder, M., Randall, A., Alloueche, A., Walraven, G., Targett, G. A. T., Alexander, N. and Sutherland, C. J. (2006). Treatment of malaria in Gambian children with chloroquine plus sulphadoxine-pyrimethamine favours survival and transmission to mosquitoes of multi-drug-resistant Plasmodium falciparum.PLoS Clinical Trials 1, e15.
27. Holmgren, G., Hamrin, J., Svard, J., Martensson, A., Gil, J. P. and Bjorkman, A. (2007). Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa. Infection, Genetics and Evolution 7, 562-569.
28. Humphreys, G. S., Merinopoulos, I., Ahmed, J., Whitty, C. J.,Mutabingwa, T. K., Sutherland, C. J. and Hallett, R. L. (2007). Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Antimicrobial Agents and Chemotherapy 51, 991-997.
29. Méndez, F., Herrera, S., Murrain, B., Gutiérrez, A., Moreno, L. A., Manzano, M., Muñoz, A. and Plowe, C. V. (2007). Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes. American Journal of Tropical Medicine and Hygiene 77, 438-443.
30. Muangnoicharoen, S., Johnson, D. J., Looareesuwan, S., Krudsood, S., Ward, S. A. (2009). Role of known molecular markers of resistance in the antimalarial potency of piperaquine and dihydroartemisinin in vitro. Antimicrobial Agents and Chemotherapy 53, 1362-1366.
31. Nassir, E., Abdel-Muhsin, A. M., Suliaman, S., Kenyon, F., Kheir, A., Geha, H., Ferguson, H. M., Walliker, D. and Babiker, H. A. (2005). Impact of genetic complexity on longevity and gametocytogenesis of Plasmodium falciparum during the dry and transmission-free season of eastern Sudan. International Journal for Parasitology 35, 49-55.
32. Noedl, H., Se, Y., Schaecher, K., Smith, B. L., Socheat, D., Fukuda, M. M. and Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium. (2008). Evidence of artemisinin-resistant malaria in western Cambodia. New England Journal of Medicine 359, 2619-2620.
33. Ord, R., Alexander, N., Dunyo, S., Hallett, R. L., Jawara, M., Targett, G. A. T., Drakeley, C. J. and Sutherland, C. J. (2007). Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum implies reduced fitness of chloroquine-resistant parasites. Journal of Infectious Diseases 196, 1613-1619.
34. Polley, S. D., Chokejindachai, W. and Conway, D. J. (2003). Allele frequency-based analyses robustly map sequence sites under balancing selection in a malaria vaccine candidate antigen. Genetics 165, 555-561.
35. Reyburn, H., Mbatia, R., Drakeley, C., Carneiro, I., Mwakasungula, E., Mwerinde, O., Saganda, K., Shao, J., Kitua, A.,Olomi, R., Greenwood, B. M. and Whitty, C. J. (2004). Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: A prospective study. British Medical Journal 329, 1212.
36. Sa, J. M. and Twu, O. (2010). Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the PfCRT SVMNT type. Malaria Journal 9, 374.
37. Sá, J. M., Twu, O., Hayton, K., Reyes, S., Fay, M. P., Ringwald, P. and Wellems, T. E. (2009). Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proceedings of the National Academy of Sciences, USA. 106, 18883-18889.
38. Shekalaghe, S. A., ter Braak, R., Daou, M., Kavishe, R., van den Bijllaardt, W., van den Bosch, S., Koenderink, J. B., Luty, A. J., Whitty, C. J., Drakeley, C., Sauerwein, R.W. and Bousema, T. (2010). In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenasedeficient (G6PD A-) individuals. Antimicrobial Agents and Chemotherapy 54, 1762-1768.
39. Sirima, S. B., Tiono, A. B., Gansané, A., Diarra, A., Ouédraogo, A., Konaté, A. T., Kiechel, J. R., Morgan, C. C., Olliaro, P. L. and Taylor, W. R. (2009). The efficacy and safety of a new fixeddose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum. Malaria Journal 8, 48.
40. Sisowath, C., Ferreira, P. E., Bustamante, L. Y., Dahlstrom, S., Martensson, A., Bjorkman, A., Krishna, S. and Gil, J. P. (2007). The role of pfmdr1 in Plasmodium falciparum tolerance to artemetherlumefantrine in Africa. Tropical Medicine and International Health 12, 736-742.
41. Sisowath, C., Petersen, I., Veiga, M. I., Martensson, A., Premji, Z., Bjorkman, A., Fidock, D. A. and Gil, J. P. (2009). In vivo selection of Plasmodium falciparum parasites carrying the chloroquine susceptible Pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. Journal of Infectious Diseases 199, 750-757.
42. Smithuis, F., Kyaw, M. K., Phe, O., Win, T., Aung, P. P., Oo, A. P., Naing, A. L., Nyo, M. Y., Myint, N. Z., Imwong, M., Ashley, E., Lee, S. J. and White, N. J. (2010). Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infectious Diseases 10, 673-681.
43. Sutherland, C. J., Drakeley, C. J. and Schellenberg, D. (2007). How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions? Malaria Journal 6, 161.
44. Sutherland, C. J., Ord, R., Dunyo, S., Jawara, M., Drakeley, C. J., Alexander, N., Coleman, R., Pinder, M., Walraven, G. and Targett, G. A. T. (2005). Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. PLoS Medicine 2, e92.
45. Sutherland, C. J. and Polley, S. D. (2011). Genomic insights into the past, current and future evolution of human parasites of the genus Plasmodium. In Genetics and Evolution of Infectious Diseases (Ed. M. Tibayrenc). Elsevier, London, 2011. ISBN: 978-0-12-384890-1.
46. Ursing, J., Kofoed, P. E., Rodrigues, A., Rombo, L. and Gil, J. P. (2007). Plasmodium falciparum genotypes associated with chloroquine and amodiaquineresistance in Guinea-Bissau. American Journal of Tropical Medicine and Hygiene. 76, 844-848.
47. Ursing, J., Kofoed, P. E., Rodrigues, A., Blessborn, D., Thoft-Nielsen, R., Björkman, A. and Rombo, L. (2011). Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial. Journal of Infectious Diseases 203, 109-116.
48. von Seidlein., L., Walraven, G., Milligan, P. J., Alexander, N., Manneh, F., Deen, J. L., Coleman, R., Jawara, M., Lindsay, S.W., Drakeley, C., De Martin, S., Olliaro, P., Bennett, S., Schim van der Loeff, M., Okunoye, K., Targett, G. A., McAdam, K. P., Doherty, J. F., Greenwood, B. M. and Pinder, M. (2003). The effect of mass administration of sulfadoxinepyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. Transactions of the Royal Society for Tropical Medicine and Hygiene. 97, 217-225.
49. Weedall, G. D., Preston, B. M. J., Thomas, A.W., Sutherland, C. J. and Conway, D. J. (2007). Differential evidence of natural selection on two leading sporozoite stage malaria vaccine candidate antigens. International Journal for Parasitology 37, 77-85.
50. Wong, R. P., Karunajeewa, H., Mueller, I., Siba, P., Zimmerman, P. A. and Davis, T. M. (2011). Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in Papua New Guinea using an extended ligase detection reaction fluorescent microsphere assay. Antimicrobial Agents and Chemotherapy 55, 798-805.
51. Zwang, J., Olliaro, P., Barennes, H., Bonnet, M., Brasseur, P., Bukirwa, H., Cohuet, S., D'Alessandro, U., Djimdé, A., Karema, C., Guthmann, J. P., Hamour, S., Ndiaye, J. L., Martensson, A., Rwagacondo, C., Sagara, I., Same-Ekobo, A., Sirima, S. B., van den Broek, I., Yeka, A., Taylor, W. R., Dorsey, G. and Randrianarivelojosia, M. (2009). Efficacy of artesunate- amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis. Malaria Journal 8, 203.